China SXT Pharmaceuticals, Inc. Comprehensive Income
China SXT Pharmaceuticals, Inc. (SXTC) reported Comprehensive Income of -$5.33 million for the 12-month period ending 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-01
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|
| 2026-03-31 | -$5.33M 20-F · filed 2026-07-01 | |
| 2025-09-30 | -$6.06M 6-K · filed 2025-12-31 | |
| 2025-03-31 | -$3.35M 20-F · filed 2026-07-01 | |
| 2024-09-30 | -$345.63K 6-K · filed 2025-12-31 | |
| 2024-03-31 | -$3.93M 20-F · filed 2026-07-01 | |
| 2023-09-30 | -$10.52M 6-K · filed 2025-03-28 | |
| 2023-03-31 | -$7.09M 20-F · filed 2025-07-31 | |
| 2022-09-30 | -$3.23M 6-K · filed 2024-04-05 | |
| 2022-03-31 | -$5.31M 20-F · filed 2024-08-13 | |
| 2021-09-30 | -$2.86M 6-K · filed 2023-02-24 | |
| 2021-03-31 | -$1.63M 20-F · filed 2023-07-31 | |
| 2020-09-30 | $2.02M 6-K · filed 2022-01-14 | |
| 2020-03-31 | -$10.93M 20-F/A · filed 2023-05-19 | |
| 2019-09-30 | -$3.16M 6-K · filed 2021-01-28 | |
| 2019-03-31 | $1.33M 20-F · filed 2021-08-13 | |
| 2018-09-30 | $1.32M 6-K/A · filed 2020-05-22 | |
| 2018-03-31 | $1.43M 20-F · filed 2020-07-31 | |
| 2017-03-31 | $1.11M 20-F · filed 2019-08-15 |